385 related articles for article (PubMed ID: 24089029)
1. The mutational landscape of phosphorylation signaling in cancer.
Reimand J; Wagih O; Bader GD
Sci Rep; 2013 Oct; 3():2651. PubMed ID: 24089029
[TBL] [Abstract][Full Text] [Related]
2. Frequent mutations in acetylation and ubiquitination sites suggest novel driver mechanisms of cancer.
Narayan S; Bader GD; Reimand J
Genome Med; 2016 May; 8(1):55. PubMed ID: 27175787
[TBL] [Abstract][Full Text] [Related]
3. Systematic analysis of somatic mutations in phosphorylation signaling predicts novel cancer drivers.
Reimand J; Bader GD
Mol Syst Biol; 2013; 9():637. PubMed ID: 23340843
[TBL] [Abstract][Full Text] [Related]
4. Candidate Cancer Driver Mutations in Distal Regulatory Elements and Long-Range Chromatin Interaction Networks.
Zhu H; Uusküla-Reimand L; Isaev K; Wadi L; Alizada A; Shuai S; Huang V; Aduluso-Nwaobasi D; Paczkowska M; Abd-Rabbo D; Ocsenas O; Liang M; Thompson JD; Li Y; Ruan L; Krassowski M; Dzneladze I; Simpson JT; Lupien M; Stein LD; Boutros PC; Wilson MD; Reimand J
Mol Cell; 2020 Mar; 77(6):1307-1321.e10. PubMed ID: 31954095
[TBL] [Abstract][Full Text] [Related]
5. Distribution bias analysis of germline and somatic single-nucleotide variations that impact protein functional site and neighboring amino acids.
Pan Y; Yan C; Hu Y; Fan Y; Pan Q; Wan Q; Torcivia-Rodriguez J; Mazumder R
Sci Rep; 2017 Feb; 7():42169. PubMed ID: 28176830
[TBL] [Abstract][Full Text] [Related]
6. MUFFINN: cancer gene discovery via network analysis of somatic mutation data.
Cho A; Shim JE; Kim E; Supek F; Lehner B; Lee I
Genome Biol; 2016 Jun; 17(1):129. PubMed ID: 27333808
[TBL] [Abstract][Full Text] [Related]
7. Cancer Gene Discovery by Network Analysis of Somatic Mutations Using the MUFFINN Server.
Han H; Lehner B; Lee I
Methods Mol Biol; 2019; 1907():37-50. PubMed ID: 30542989
[TBL] [Abstract][Full Text] [Related]
8. Systematic analysis of the intersection of disease mutations with protein modifications.
Simpson CM; Zhang B; Hornbeck PV; Gnad F
BMC Med Genomics; 2019 Jul; 12(Suppl 6):109. PubMed ID: 31345222
[TBL] [Abstract][Full Text] [Related]
9. Protein dynamics analysis identifies candidate cancer driver genes and mutations in TCGA data.
Sayılgan JF; Haliloğlu T; Gönen M
Proteins; 2021 Jun; 89(6):721-730. PubMed ID: 33550612
[TBL] [Abstract][Full Text] [Related]
10. A Pan-Cancer Catalogue of Cancer Driver Protein Interaction Interfaces.
Porta-Pardo E; Garcia-Alonso L; Hrabe T; Dopazo J; Godzik A
PLoS Comput Biol; 2015 Oct; 11(10):e1004518. PubMed ID: 26485003
[TBL] [Abstract][Full Text] [Related]
11. Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes.
Leiserson MD; Vandin F; Wu HT; Dobson JR; Eldridge JV; Thomas JL; Papoutsaki A; Kim Y; Niu B; McLellan M; Lawrence MS; Gonzalez-Perez A; Tamborero D; Cheng Y; Ryslik GA; Lopez-Bigas N; Getz G; Ding L; Raphael BJ
Nat Genet; 2015 Feb; 47(2):106-14. PubMed ID: 25501392
[TBL] [Abstract][Full Text] [Related]
12. OncoVar: an integrated database and analysis platform for oncogenic driver variants in cancers.
Wang T; Ruan S; Zhao X; Shi X; Teng H; Zhong J; You M; Xia K; Sun Z; Mao F
Nucleic Acids Res; 2021 Jan; 49(D1):D1289-D1301. PubMed ID: 33179738
[TBL] [Abstract][Full Text] [Related]
13. De novo discovery of mutated driver pathways in cancer.
Vandin F; Upfal E; Raphael BJ
Genome Res; 2012 Feb; 22(2):375-85. PubMed ID: 21653252
[TBL] [Abstract][Full Text] [Related]
14. Reconfiguring phosphorylation signaling by genetic polymorphisms affects cancer susceptibility.
Wang Y; Cheng H; Pan Z; Ren J; Liu Z; Xue Y
J Mol Cell Biol; 2015 Jun; 7(3):187-202. PubMed ID: 25722345
[TBL] [Abstract][Full Text] [Related]
15. Identifying Driver Interfaces Enriched for Somatic Missense Mutations in Tumors.
Ozturk K; Carter H
Methods Mol Biol; 2019; 1907():51-72. PubMed ID: 30542990
[TBL] [Abstract][Full Text] [Related]
16. Identification of constrained cancer driver genes based on mutation timing.
Sakoparnig T; Fried P; Beerenwinkel N
PLoS Comput Biol; 2015 Jan; 11(1):e1004027. PubMed ID: 25569148
[TBL] [Abstract][Full Text] [Related]
17. Identifying overlapping mutated driver pathways by constructing gene networks in cancer.
Wu H; Gao L; Li F; Song F; Yang X; Kasabov N
BMC Bioinformatics; 2015; 16 Suppl 5(Suppl 5):S3. PubMed ID: 25859819
[TBL] [Abstract][Full Text] [Related]
18. Tissue-Specific Signaling Networks Rewired by Major Somatic Mutations in Human Cancer Revealed by Proteome-Wide Discovery.
Zhao J; Cheng F; Zhao Z
Cancer Res; 2017 Jun; 77(11):2810-2821. PubMed ID: 28364002
[TBL] [Abstract][Full Text] [Related]
19. ActiveDriverDB: human disease mutations and genome variation in post-translational modification sites of proteins.
Krassowski M; Paczkowska M; Cullion K; Huang T; Dzneladze I; Ouellette BFF; Yamada JT; Fradet-Turcotte A; Reimand J
Nucleic Acids Res; 2018 Jan; 46(D1):D901-D910. PubMed ID: 29126202
[TBL] [Abstract][Full Text] [Related]
20. Pan-Cancer Analysis Reveals the Functional Importance of Protein Lysine Modification in Cancer Development.
Chen L; Miao Y; Liu M; Zeng Y; Gao Z; Peng D; Hu B; Li X; Zheng Y; Xue Y; Zuo Z; Xie Y; Ren J
Front Genet; 2018; 9():254. PubMed ID: 30065750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
